SILK ROAD MEDICAL INC (SILK) Stock Price & Overview
NASDAQ:SILK • US82710M1009
The current stock price of SILK is 27.49 USD. Today SILK is down by -0.04%. In the past month the price increased by 1.36%. In the past year, price increased by 74.98%.
SILK Key Statistics
- Market Cap
- 1.117B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.44
- Dividend Yield
- N/A
SILK Stock Performance
SILK Stock Chart
SILK Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to SILK. When comparing the yearly performance of all stocks, SILK is one of the better performing stocks in the market, outperforming 90.01% of all stocks.
SILK Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SILK. While SILK seems to be doing ok healthwise, there are quite some concerns on its profitability.
SILK Earnings
On August 7, 2024 SILK reported an EPS of -0.42 and a revenue of 51.24M. The company missed EPS expectations (-9.6% surprise) and beat revenue expectations (1.28% surprise).
SILK Forecast & Estimates
13 analysts have analysed SILK and the average price target is 22.54 USD. This implies a price decrease of -18% is expected in the next year compared to the current price of 27.49.
For the next year, analysts expect an EPS growth of -3.77% and a revenue growth 16.35% for SILK
SILK Groups
Sector & Classification
SILK Financial Highlights
Over the last trailing twelve months SILK reported a non-GAAP Earnings per Share(EPS) of -1.44. The EPS decreased by -2.13% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -20.96% | ||
| ROE | -36.55% | ||
| Debt/Equity | 0.49 |
SILK Ownership
SILK Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.83 | 187.913B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.89 | 170.203B | ||
| SYK | STRYKER CORP | 22.3 | 129.047B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.6 | 101.721B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.46 | 49.099B | ||
| IDXX | IDEXX LABORATORIES INC | 38.53 | 45.48B | ||
| BDX | BECTON DICKINSON AND CO | 11.71 | 45.453B | ||
| RMD | RESMED INC | 18.93 | 33.857B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.053B | ||
| DXCM | DEXCOM INC | 25.67 | 25.116B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.92 | 18.115B | ||
| HOLX | HOLOGIC INC | 15.32 | 16.79B | ||
| PODD | INSULET CORP | 36.52 | 16.619B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SILK
Company Profile
Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. The company is headquartered in Sunnyvale, California and currently employs 474 full-time employees. The company went IPO on 2019-04-04. The firm has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. The company manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.
Company Info
IPO: 2019-04-04
SILK ROAD MEDICAL INC
1213 Innsbruck Dr
Sunnyvale CALIFORNIA 94089 US
CEO: Erica J. Rogers
Employees: 474
Phone: 16505669060
SILK ROAD MEDICAL INC / SILK FAQ
What does SILK do?
Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. The company is headquartered in Sunnyvale, California and currently employs 474 full-time employees. The company went IPO on 2019-04-04. The firm has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. The company manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.
Can you provide the latest stock price for SILK ROAD MEDICAL INC?
The current stock price of SILK is 27.49 USD. The price decreased by -0.04% in the last trading session.
Does SILK stock pay dividends?
SILK does not pay a dividend.
How is the ChartMill rating for SILK ROAD MEDICAL INC?
SILK has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is SILK stock listed?
SILK stock is listed on the Nasdaq exchange.
Can you provide the number of employees for SILK ROAD MEDICAL INC?
SILK ROAD MEDICAL INC (SILK) currently has 474 employees.